Yassine Belkhouja, CEO
Carries the LUMEN architecture, the .col format (USPTO provisional 2026-04-04), the 264 patents in submission, the sovereign Canadian deployment.
Yassine Belkhouja, Founder & CEO. Khairallah Belkhouja, Co-Founder & Chief Medical Officer. PulsarOS Intelligence Inc., Ottawa. Sovereign Canadian deeptech.
Carries the LUMEN architecture, the .col format (USPTO provisional 2026-04-04), the 264 patents in submission, the sovereign Canadian deployment.
Senior consultant intensivist. Twenty-eight years of bedside critical care. Trilingual practice. Trained at the Faculty of Medicine, University of Tunis, 1988 to 1996.
No feature ships unless both signatures hold. The CEO writes the architecture. The CMO signs every clinical claim.
We build the platform a senior consultant would countersign without hesitation. Anything less is not worth shipping.
Ottawa, Canada. Sovereign Canadian deeptech. Federally incorporated. Patent counsel on file (Smart & Biggar, Ottawa). 264 patents in submission. .col format provisional filed USPTO 2026-04-04. Fully self-hosted infrastructure on sovereign Canadian hardware.
The technologist and the consultant on the same call sheet. The CEO holds the architecture. The CMO holds the standard. The decision is countersigned by both before any feature ships.